Key facts
- This page summarizes Tyrone Miller's Form 4 filing for 60 DEGREES PHARMACEUTICALS, INC. (SXTP).
- 5 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 21 May 2024, 20:22.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Award
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Options Exercise
Options Exercise
Additional SEC filing notes
Footnote F1
Tyrone Miller was granted a total of 75,000 restricted stock units ("RSUs") on November 21, 2023 that were fully vested as of the grant date. 60,000 shares underlying the RSUs were settled on April 12, 2024 (the "4/24 Shares"). Tyrone Miller owned 101,928 shares of common stock immediately prior to the issuance of the 4/24 Shares. As of April 12, 2024, Tyrone Miller owned a total of 161,928 shares of common stock.
Footnote F2
15,000 shares underlying the RSUs were settled on May 16, 2024 (the "5/24 Shares"). Tyrone Miller owned 161,928 shares of common stock immediately prior to the issuance of the 5/24 Shares. As of May 16, 2024, Tyrone Miller owned a total of 176,928 shares of common stock.
Footnote F3
Tyrone Miller was granted a total of 75,000 restricted stock units on November 21, 2023 that were fully vested as of the grant date. Each RSU represents the right to receive, at settlement, one share of common stock.
Footnote F4
60,000 shares underlying the RSUs were settled on April 12, 2024. After the settlement of the shares of common stock that were underlying the 60,000 RSUs, Tyrone Miller owned a total of 15,000 RSUs.
Footnote F5
15,000 shares underlying the RSUs were settled as of May 16, 2024. After the settlement of the shares of common stock that were underlying the 15,000 RSUs, Tyrone Miller did not own any RSUs.